ISSN: 2155-6105

Zeitschrift für Suchtforschung und -therapie

Offener Zugang

Unsere Gruppe organisiert über 3000 globale Konferenzreihen Jährliche Veranstaltungen in den USA, Europa und anderen Ländern. Asien mit Unterstützung von 1000 weiteren wissenschaftlichen Gesellschaften und veröffentlicht über 700 Open Access Zeitschriften, die über 50.000 bedeutende Persönlichkeiten und renommierte Wissenschaftler als Redaktionsmitglieder enthalten.

Open-Access-Zeitschriften gewinnen mehr Leser und Zitierungen
700 Zeitschriften und 15.000.000 Leser Jede Zeitschrift erhält mehr als 25.000 Leser

Indiziert in
  • CAS-Quellenindex (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Öffnen Sie das J-Tor
  • Genamics JournalSeek
  • Akademische Schlüssel
  • JournalTOCs
  • SafetyLit
  • Nationale Wissensinfrastruktur Chinas (CNKI)
  • Elektronische Zeitschriftenbibliothek
  • RefSeek
  • Hamdard-Universität
  • EBSCO AZ
  • OCLC – WorldCat
  • SWB Online-Katalog
  • Virtuelle Bibliothek für Biologie (vifabio)
  • Publons
  • Genfer Stiftung für medizinische Ausbildung und Forschung
  • Euro-Pub
  • ICMJE
Teile diese Seite

Abstrakt

The Imperative for Expanding the Asam Continuum of Care: Exploring Predictive Factors of Long-Term Residential Substance Use Disorder Treatment Outcomes

Ashleigh Herrera

Introduction: Despite the rise in opioid and amphetamine morbidity and mortality, only about 1% of persons with substance use disorders (SUDs) pursue specialty treatment. Furthermore, the SUD treatment dropout and attrition rates remain high with less than 42% of clients completing treatment across settings. However, limited research has focused on predictive factors of treatment completion for long-term residential (LTR) SUD treatment, especially among clients with co-occurring psychiatric conditions (CODs).

Methods: A de-identified dataset was obtained from an abstinence-based LTR SUD treatment facility in an urban county. The dataset included a sample of 200 clients admitted between August 1, 2017, and March 1, 2018. The dataset included information provided by the clients during their ASAM Multidimensional Assessment and treatment disposition from their Discharge/Transfer Form. The sole dependent variable of interest in this study was the clients’ treatment disposition.

Results: Significant predictor variables of LTR SUD treatment noncompletion at p < .05 were past 30 days of use of primary substance used reported at intake (OR = 1.069, p < .001), mental health treatment and symptoms (p < .01), number of inpatient psychiatric episodes (OR = 1.375, p < .019), and readiness for change (p < .03). There were no significant predictors for participants who completed residential SUD treatment and transferred to a lower level of SUD care. However, past 30 days of use of primary substance used reported at intake, number of inpatient psychiatric episodes, and mental health treatment and symptoms predicted treatment outcomes for participants who left treatment and those who received an administrative discharge compared to those participants who completed residential SUD treatment and did not pursue aftercare services.

Conclusions: Clients reporting high levels of pretreatment substance use, including MA, at time of assessment should be referred to withdrawal management to decrease the likelihood of treatment noncompletion. Continuity of care for clients discharging from inpatient psychiatric hospitalization episodes is critical to improve their likelihood of completing LTR SUD treatment. Additional states need to expand their ASAM Continuum of Care and apply for 1115 Section Waivers to enhance the quality of care and treatment outcomes for clients with CODs.

Haftungsausschluss: Dieser Abstract wurde mit Hilfe von Künstlicher Intelligenz übersetzt und wurde noch nicht überprüft oder verifiziert.